HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Board Certifications: Internal Medicine and Medical Oncology
Specializations: Breast Cancer
Languages: English
Locations: Sparta, NJ
For more than 15 years Dr. May Abdo-Matkiwsky has been treating patients in the Sussex County community and participates in several fundraising events for the community and public school system. Dr. Abdo-Matkiwsky has a medical license in New Jersey and New York and has published several articles in peer review journals over the years. Dr. Abdo-Matkiwsky has been an adjunct professor in hematology/ oncology at Touro College of Osteopathic Medicine for the last 5 years. She Directs the Tumor Board at Newton Medical Center. Dr. Abdo-Matkiwsky is actively involved in breast cancer research and has enrolled patients in multiple clinical trials.
New York Institute of Technology College of Osteopathic Medicine (Medical Degree)
University of Medicine and Dentistry of New Jersey (Internal Medicine)
Beth Israel Medical Center, New York, fellowship in hematology/medical oncology
American Society of Clinical Oncology and American Society of Hematology, Cancer Committee, co-chair, Newtown Medical Center, Sussex/Warren Regional Task Force on Breast Cancer for the past 10 years
Newton Medical Center, Hackettstown Medical Center and Saint Clare’s Hospital
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.